Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, whic...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/full |
id |
doaj-ee1f78f4a641477ead9d34e6201a6e21 |
---|---|
record_format |
Article |
spelling |
doaj-ee1f78f4a641477ead9d34e6201a6e212021-09-16T04:52:56ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.731100731100Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 InfectionDawei Cui0Yuan Tang1Yuan Tang2Qi Jiang3Daixi Jiang4Yun Zhang5Yan Lv6Dandan Xu7Jian Wu8Jue Xie9Chengping Wen10Liwei Lu11Liwei Lu12Department of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, Hong Kong, SAR ChinaChongqing International Institute for Immunology, Chongqing, ChinaDepartment of Blood Transfusion, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaSchool of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaSchool of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, Hong Kong, SAR ChinaChongqing International Institute for Immunology, Chongqing, ChinaCoronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, which is closely regulated by follicular helper T (Tfh) cells. Tfh cells play a central role in promoting germinal center reactions and driving cognate B cell differentiation for antibody secretion. Available studies indicate a close relationship between virus-specific Tfh cell-mediated immunity and SARS-CoV-2 infection progression. Although several lines of evidence have suggested that Tfh cells contribute to the control of SARS-CoV-2 infection by eliciting neutralizing antibody productions, further studies are needed to elucidate Tfh-mediated effector mechanisms in anti-SARS-CoV-2 immunity. Here, we summarize the functional features and roles of virus-specific Tfh cells in the immunopathogenesis of SARS-CoV-2 infection and in COVID-19 vaccines, and highlight the potential of targeting Tfh cells as therapeutic strategy against SARS-CoV-2 infection.https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/fullCOVID-19SARS-CoV-2Tfh cellsB cellsneutralizing antibody |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dawei Cui Yuan Tang Yuan Tang Qi Jiang Daixi Jiang Yun Zhang Yan Lv Dandan Xu Jian Wu Jue Xie Chengping Wen Liwei Lu Liwei Lu |
spellingShingle |
Dawei Cui Yuan Tang Yuan Tang Qi Jiang Daixi Jiang Yun Zhang Yan Lv Dandan Xu Jian Wu Jue Xie Chengping Wen Liwei Lu Liwei Lu Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection Frontiers in Immunology COVID-19 SARS-CoV-2 Tfh cells B cells neutralizing antibody |
author_facet |
Dawei Cui Yuan Tang Yuan Tang Qi Jiang Daixi Jiang Yun Zhang Yan Lv Dandan Xu Jian Wu Jue Xie Chengping Wen Liwei Lu Liwei Lu |
author_sort |
Dawei Cui |
title |
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection |
title_short |
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection |
title_full |
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection |
title_fullStr |
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection |
title_full_unstemmed |
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection |
title_sort |
follicular helper t cells in the immunopathogenesis of sars-cov-2 infection |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-09-01 |
description |
Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, which is closely regulated by follicular helper T (Tfh) cells. Tfh cells play a central role in promoting germinal center reactions and driving cognate B cell differentiation for antibody secretion. Available studies indicate a close relationship between virus-specific Tfh cell-mediated immunity and SARS-CoV-2 infection progression. Although several lines of evidence have suggested that Tfh cells contribute to the control of SARS-CoV-2 infection by eliciting neutralizing antibody productions, further studies are needed to elucidate Tfh-mediated effector mechanisms in anti-SARS-CoV-2 immunity. Here, we summarize the functional features and roles of virus-specific Tfh cells in the immunopathogenesis of SARS-CoV-2 infection and in COVID-19 vaccines, and highlight the potential of targeting Tfh cells as therapeutic strategy against SARS-CoV-2 infection. |
topic |
COVID-19 SARS-CoV-2 Tfh cells B cells neutralizing antibody |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/full |
work_keys_str_mv |
AT daweicui follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT yuantang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT yuantang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT qijiang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT daixijiang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT yunzhang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT yanlv follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT dandanxu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT jianwu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT juexie follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT chengpingwen follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT liweilu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection AT liweilu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection |
_version_ |
1717378438092816384 |